-
Use of 55 PET radiotracers under approval of a Radioactive Drug Research Comm...
Abstract Background In the US, EU and elsewhere, basic clinical research studies with positron emission tomography (PET) radiotracers that are generally recognized as safe and... -
SiO2 and TiO2 nanoparticles synergistically trigger macrophage inflammatory r...
Abstract Silicon dioxide (SiO2) nanoparticles (NPs) and titanium dioxide (TiO2) NPs are the most widely used inorganic nanomaterials. Although the individual toxicities of SiO2... -
Delta opioid peptide [d-Ala2, d-Leu5] enkephalin confers neuroprotection by a...
Abstract Background Ischemic stroke poses a severe risk to human health worldwide, and currently, clinical therapies for the disease are limited. Delta opioid receptor... -
Risks of miscarriage and inadvertent exposure to artemisinin derivatives in t...
Abstract Background The artemisinin anti-malarials are widely deployed as artemisinin-based combination therapy (ACT). However, they are not recommended for uncomplicated... -
Differences between evidence-based recommendations and actual clinical practi...
Abstract Background International guidelines recommend that tocolytic therapy be restricted to a single 48-h application. However, multiple cycles of tocolytic therapy and... -
The influence of pregnancy on the pharmacokinetic properties of artemisinin c...
Abstract Background Pregnancy has been reported to alter the pharmacokinetic properties of anti-malarial drugs, including the different components of artemisinin-based...
